Med Ed Report briefs

Unbound Medicine was named the official electronic publisher of the web- and mobile-based versions of Johns Hopkins' Antibiotic (ABX), Diabetes and HIV POC-IT Guides. The clinical decision support tool provides information to healthcare professionals at the point of care.

Doug Young, PhD, was named VP, Touchpoint clinical solutions at Publicis Touchpoint Solutions. The firm specializes in clinical health educator programs, MSL teams and integrated adherence and retention programs. Young served most recently as VP, global medical affairs, BMS.

Elsevier said the Cleveland Clinic physicians will develop ongoing content updates and reviews for Elsevier's First Consult clinical reference tool, according to a new strategic collaboration announced by the medical publisher. The Clinic currently provides point-of-care CME credit to users of Elsevier's First Consult and MD Consult tools.

Vindico Medical Education received accreditation with commendation as a provider of CME by the ACCME. ACCME accreditation with commendation, also known as Level 3 accreditation, ranks Vindico among the top 8% of providers of CME in the US.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.